MOSCOW (Reuters) – Moscow’s Gamaleya Institute, the developer of first Russian vaccine against COVID-19, said on Wednesday that volunteers in the trials for the Sputnik V shot will no longer receive placebos, RIA news agency reported.
(Reporting by Maria Kiselyova; Writing by Gabrielle Tétrault-Farber; Editing by Andrew Heavens)
